Fluxus
Pre-clinicalFluxus is pioneering bioanalytical solutions that combine ultrasensitivity with the ability to detect a wide range of biomolecular targets in low-complex configurations adaptable to any testing environment.
Founded
2016
Focus
Synthetic BiologyMetabolic
About
Fluxus is pioneering bioanalytical solutions that combine ultrasensitivity with the ability to detect a wide range of biomolecular targets in low-complex configurations adaptable to any testing environment.
Funding History
1Total raised: $3.2M
Seed$3.2MY CombinatorSep 15, 2021
Company Info
TypePrivate
Founded2016
LocationSan Francisco, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile